A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group.
第一作者:
E,Bajetta
第一单位:
Division of Medical Oncology B, Instituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
作者:
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);雄烯二酮(Androstenedione);抗肿瘤药(Antineoplastic Agents);芳香酶抑制剂(Aromatase Inhibitors);乳腺肿瘤(Breast Neoplasms);雌二醇(Estradiol);雌酮(Estrone);女(雌)性(Female);人类(Humans);注射, 肌肉内(Injections, Intramuscular);中年人(Middle Aged);绝经后期(Postmenopause);存活率分析(Survival Analysis);治疗结果(Treatment Outcome)
DOI
10.1023/a:1008270131789
PMID
9296217
发布时间
2020-02-03
- 浏览32
Annals of oncology
649-54页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



